Becton Dickinson & Co(BDX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 4:03 PM ET (Korea 10/30 05:03)
Full metrics table
| Index | S&P 500 | P/E | 58.86 | EPS (ttm) | 3.32 | Insider Own | 0.2% | Shs Outstand | 272.4M | Perf Week | 0.42% |
| Market Cap | 53.16B | Forward P/E | 14.73 | EPS next Y | 4.53% | Insider Trans | -2.19% | Shs Float | 271.8M | Perf Month | 7.25% |
| Enterprise Value | 69.10B | PEG | 1.9 | EPS next Q | 4.07 | Inst Own | 99.75% | Short Float | 3.28% | Perf Quarter | 17.96% |
| Income | 0.94B | P/S | 2.55 | EPS this Y | 11.98% | Inst Trans | -1.7% | Short Ratio | 5.1 | Perf Half Y | 34.31% |
| Sales | 20.84B | P/B | 2.18 | EPS next 5Y | 7.76% | ROA | 2.44% | Short Interest | 8.91M | Perf YTD | 27.96% |
| Book/sh | 89.64 | P/C | 61.53 | EPS past 3/5Y | -0.35% 16.45% | ROE | 5.17% | 52W High | -2.65% ($200.47) | Perf Year | 34.81% |
| Cash/sh | 3.17 | P/FCF | 20.99 | Sales past 3/5Y | 4.99% 6.32% | ROIC | 2.48% | 52W Low | 53.02% ($127.54) | Perf 3Y | -1.3% |
| Dividend Est. | $4.02 (2.06%) | EV/EBITDA | 13.15 | EPS Y/Y TTM | -40.38% | Gross Margin | 46.44% | Volatility(W/M) | 1.86% 2.08% | Perf 5Y | 6.73% |
| Dividend TTM | 3.98 | EV/Sales | 3.32 | Sales Y/Y TTM | -2.56% | Oper. Margin | 14.54% | ATR (14) | 3.92 | Perf 10Y | 51.81% |
| Dividend Ex-Date | 2026/9/9 | Quick Ratio | 0.51 | EPS Q/Q | -31.44% | Profit Margin | 4.52% | RSI (14) | 60.95 | Recom | 2.21 |
| Dividend Gr. 3/5Y | 6.13% 5.65% | Current Ratio | 0.87 | Sales Q/Q | -9.55% | SMA20 | 3.32% ($188.89) | Beta | 0.24 | Target Price | $193.31 |
| Payout | 71.53% | Debt/Eq | 0.69 | Earnings | 2026/11/5 | SMA50 | 4.82% ($186.19) | Rel Volume | 1 | Prev Close | $195.03 |
| Employees | 72000 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 2.82% 1.96% | SMA200 | 17.85% ($165.6) | Avg Volume(3M) | 1.75M | Price | $195.16 |
| IPO | 1963/9/25 | Option/Short | Yes/Yes | Trades | 22644 | Volume | 1,740,473 | Change | 0.07% |
💉 This is a US-based large-cap medical device company that supplies medical syringes, diagnostic equipment, and life science instruments. Founded in 1897 and headquartered in New Jersey, it holds a globally leading position in drug delivery, specimen collection, and clinical diagnostics, and is a healthcare stock with a steady track record of dividend increases.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded about as much as usual. That is 100% of its average volume.
Next earnings report: November 5
7 days to go.
BDX earns moderately but has a weak balance sheet
Of every $100 in sales, $14.54 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.0% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,473. Peers typically go for $1,892. Compared with its own 5-year average, it is 38% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +6.7%. The S&P 500 did +69% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 2.06% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 99.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 51 in the industry
Based on market cap of $53B.
BDX#2 Becton Dickinson & Co $53B PER 58.9 
MDLN#3 Medline Inc $43B PER 38.0 
RMD#4 Resmed Inc $35B PER 24.0 
ALC#5 Alcon Inc $34B PER 53.5 
WST#6 West Pharmaceutical Services Inc $28B PER 51.6 
FAQ
What kind of company is BDX?
BDX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of BDX?
The market cap of BDX is approximately $53.2B, ranking 306 within its sector.
Does BDX pay dividends?
BDX has a dividend yield of approximately 2.06%, with an annual dividend of $4.02.
What is the P/E ratio of BDX?
BDX has a P/E ratio of approximately 58.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BDX?
BDX has recorded a 52-week high of $200.47 and a low of $127.54.
